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Abstract
Decellularized scaffolds have been found to be excellent platforms for tissue engineering applications. The attempts are still
being made to optimize a decellularization protocol with successful removal of the cells with minimal damages to
extracellular matrix components. We examined twelve decellularization procedures using different concentrations of Sodium
dodecyl sulfate and Triton X-100 (alone or in combination), and incubation time points of 15 or 30 min. Then, the potential
of the decellularized scaffold as a three-dimensional substrate for colony formation capacity of mouse spermatogonial stem
cells was determined. The morphological, degradation, biocompatibility, and swelling properties of the samples were fully
characterized. The 0.5%/30 SDS/Triton showed optimal decellularization with minimal negative effects on ECM (P ≤ 0.05).
The swelling ratios increased with the increase of SDS and Triton concentration and incubation time. Only 0.5%/15 and 30
SDS showed a significant decrease in the SSCs viability compared with other groups (P < 0.05). The SSCs colony formation
was clearly observed under SEM and H&E stained slides. The cells infiltrated into the subcutaneously implanted scaffold at
days 7 and 30 post-implantation with no sign of graft rejection. Our data suggest the %0.5/30 SDS/Triton as an excellent
platform for tissue engineering and reproductive biology applications.
Graphical Abstract
1 Introduction
About 15% of couples have infertility problems, half of
which are related to men [1]. In recent years, many tech-
niques have improved fertility in men [2, 3]. Therefore,
after a century of studies of spermatogenesis in different
species, it is still a good way to treat infertility in people
with congenital testicular abnormalities (Klein–Filter
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syndrome), azoospermic men who do not have spermatids,
and also, there are no immature patients with cancer who
have suffered spermatogenic cell damage during che-
motherapy and radiotherapy [4]. This low population of
spermatogonia in mice is responsible for producing 109
sperm per day [5]. Therefore, the aim of the researchers
was to investigate the proliferation and differentiation of
spermatogonia to produce functional sperm in vitro [6]. In
this regard, a wide range of 3-dimensional (3-D) tissue
engineering scaffolds have been made from synthetic and
biological materials, each of which has its advantages and
disadvantages [7, 8]. Scaffolds place the cells in contact
with nutrients and oxygen, and facilitate the disposal of
waste materials [9]. Tissue engineering scaffolds can
provide a 3-D microstructure with tunable biomechanical
and biological properties to achieve a biomimetic substrate
for treatment of damaged tissues such as skin [10], carti-
lage [11], eye [12], or specific lineage differentiation of
stem cells both in vitro and in vivo [13].
Decellularization of tissue and production of engineering
scaffolds from extracellular matrix (ECM) components are
considered as an excellent biomedical platform that provides
a normal tissue biomimetic micro/macrostructure with many
biological factors required for cell migration, proliferation,
and further conduction/promoting differentiation [14–16]. To
date, several decellularization protocols have been examined
for successful and safe decellularization of tissues. It is well
documented that decellularization and preservation processes
profoundly affect the biomechanical and biological properties
of tissue. Therefore, the intensive efforts are still being made
to find an optimized and safe decellularization and pre-
servation methods with full removal of cells and cell frag-
ments with minimal damage to ECM [17, 18].
In the current study, we aim to optimize the decellular-
ization of human placenta using different decellularization
agents and time points for tissue engineering and repro-
duction sciences applications. Placenta is excreted after
birth, and so is easily available with a large amount of
ECM. Placenta is an excellent source of biological materials
for production of allograft scaffolds [19, 20]. One of the
advantages of using placenta of tissue is the lack of an
invasive method for tissue acquisition [21]. ECM of pla-
centa contains various fibers including fibronectin, laminin,
and collagen type I, III, IV, V, and VI [22]. It is also a rich
reservoir for different types of growth factors and cytokines
such as epidermal growth factor (EGF), transforming
growth factor (TGF-β, β, fibroblast growth factor (FGF),
platelet-derived growth factor (PDGF), and vascular endo-
thelial growth factor (VEGF) [23].
Almost all decellularization procedures are detergent-
(ionic and anionic-based detergents), freeze/thawed- and
mechanical-based protocols. Sodium dodecyl sulfate
(SDS, as anionic detergent) and Triton X100 (as nonionic
detergent) have widely been used for decellularization of
various tissues. It is reported that SDS is the most effective
detergent for removal of the cells from tissues. However,
SDS also showed to have toxicity properties against human
cells and also causes extensive damages to tissues, depen-
dent to its concentration and incubation time point [18, 19].
Here, we examine twelve decellularization protocols
using different concentrations of SDS and Triton X100 and
treatment time points for decellularization of human pla-
centa and fabrication of placental-derived macroporous
scaffolds with 3-D microstructure. The successful decel-
lularization and damages to ECM are investigated with
DNA count and various tissue staining. The morphological,
biomechanical, biochemical, and biological properties of
the scaffold are fully characterized in vitro and in vivo. The
potential of the optimized placental macroporous scaffold
for culture, growth, attachment, and colony formation of
SSCs are then determined.
2 Materials and methods
In this study, we compared different protocols of decel-
lularization of human placenta, and fully characterized the
decellularization, mechanical and biological properties. The
potential of the acellular 3-D sponge placenta scaffolds for
SSCs culture and growth was studied in vitro.
2.1 Tissue collection
The study was conducted under the Declaration of Helsinki.
Five human placentas were obtained from Akbar-Abadi,
Hospital in Tehran and after ethical approval the informed
consent from cesarean deliveries at the Iran University of
medical sciences was taken (Approval ID: IR.IUMS.FMD.
REC 1396.33110).
2.2 Decellularization procedures
In the first step, the placenta was washed with distilled
water for separating the blood clots [24]. The amniotic and
chorionic membranes and umbilical cord were completely
isolated and removed and considered tissue was split into
small pieces as much as possible and homogenized for
10 min on the ice using a blender. The homogenized pla-
centa washed by distilled water and centrifuged at 1500
RPM for 10 min. The samples were treated with different
concentrations of Triton (Triton X100, 9002-93-1, Sigma-
Aldrich) and SDS (sodium dodecyl sulfate, Sigma-Aldrich)
for 15 or 30 min, in twelve decellularization groups
(Table 1). After decellularization, the samples were rinsed
with distilled water. The treated subgroups of ECM were
centrifuged at 2000 RPM and rinsed with distilled water
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two times for 8 days in a cold room on the shaker, until the
extraction of detergents. ECM was gently poured into 24
wells, frozen at –80 °C, and dried (Alpha 1–2 LD plus,
Christ, Germany) overnight. All the decellularized scaffolds
were kept at −80 °C until use, maximum for 1 month. The
process of placenta decellularization was done in three
replications. Decellularized ECM sheets were washed
4 times by PBS and penicillin (300 IU/mL), streptomycin
(300 μg/mL), every 15 min, and sterilized by UV before
SSCs in vitro culture.
2.3 Characterizations
2.3.1 H&E and DAPI staining
The samples were fixed with 10% formalin, dehydrated
through a graded series of alcohol; 50, 70, 80, 95, and 3 ×
100%, embedded in paraffin, and cut at 5 µm thickness by a
microtome. The slides were stained with hematoxylin and
eosin (H&E) and 4′, 6-diamidino-2-phenylindole (DAPI,
Thermo Scientific). The H&E and DAPI stained slides were
visualized under a light microscope (Olympus, Japan) at
×400 magnifications using an Olympus DP72 digital cam-
era, and a fluorescence microscope, respectively. Cell nuclei
in H&E and DAPI staining are stained in blue. The cell’s
nucleus of the samples was measured in 10 random fields
and compared between the decellularization groups.
2.3.2 DNA content
To quantify the DNA content in native and decellularized
tissues, samples were lyophilized and then the extraction of
DNA was done from ~7 mg of dry samples by the QiaAmp
mini kit (Qiagen, USA) according to manufacturer’s pro-
tocol. Finally, the NanoDrop spectrophotometer (2000C,
Thermo Fisher Scientific, USA) used to determine the
concentration of the total DNA (ng/mg).
2.3.3 Orcein, alcian blue, and Masson’s trichrome
The sectioned slides were stained with Masson’s trichrome
(Sigma-Aldrich, USA), 1% Alcian Blue (diluted in 0.1 M
HCl, Sigma-Aldrich, USA), and Orcein (Taenzer-Unna) for
visualization of collagen fibers, glycosaminoglycan (GAG),
and elastic fibers, respectively. All techniques were per-
formed in accordance with the manufacturer’s instructions
(n= 3 per condition, from all treated placenta). Images were
captured on ten random fields by a light microscope and
analyzed by program ImageJ (US National Institute of
Health, Bethesda, MD).
2.3.4 Mechanical behavior
The mechanical properties of the decellularized samples
were measured using a Universal Testing Machine
(Hct400/25, Zwick/Roell) with a 10 kg load cell and a
crosshead loading rate of 0.5 mm.min−1. The cylindrical
samples presented for each type of decellularized method
were all 4 mm in diameter and 8 mm in height. The
obtained strain-strain curves were analyzed for measure-
ment of the mechanical parameters such as compressive
strength and Young’s modulus. The ultimate compressive
strength of materials was specified as value of uniaxial
compressive stress, which broke the sample. By calculating
the ratio of stress to strain in the linear elastic region, the
Young’s modulus was determined.
2.3.5 Degradability assays
The in vitro degradation assay of cylindrical decellularized
scaffolds was performed for three samples from each group
with the same weight, which were soaked into 5 ml of PBS
at pH= 7.4 and 37 °C. At a predetermined time point (3, 7,
10, 14, 21, and 30 days), each of the samples was taken out
and was freeze-dried for 12 h after surface wiping and their
weight recorded. Water absorption and sample weight loss
were calculated by Eqs. (1) and (2), respectively:
Water absorption %ð Þ : Wt W0Þ=W0  100%
 ð1Þ
Degradation %ð Þ : W0 Wdð Þ=W0  100% ð2Þ
where W0 is the initial dry weight, Wd is the dry sample
weight after removal from the medium, and Wt is the wet
sample weight after removal. Furthermore, pH values of the
solutions during scaffold soaking were recorded.
Table 1 Different procedures used for decellularization of human
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2.3.6 The swelling behavior
The equilibrated swelling ratio (ESR) of each type of
decellularized scaffolds was measured using gravimetric
method. The cylindrical sample with same size was
immersed in PBS at 37 °C for 24 h. After reaching the
swelling equilibrium, the scaffolds were removed from the
buffer solution, the excess water of sample was removed by
filter paper and swollen samples were weighed. The ESR
was calculated by following equation:
ESR ¼ WsW0ð Þ=W0 100%
In this equation, Ws and W0 parameters represent the
stolen and initial weight of scaffold, respectively. The
experiments were carried out for three samples of
each group.
2.4 Microstructure of scaffold
2.4.1 Scanning electron microscopy
First, we coated fixed samples with gold [25]; then, their
morphology was explored using Scanning Electron Micro-
scopy (SEM, AIS2100; Seron Technology, Gyeonggi-do,
South Korea).
2.4.2 Pore size
The average diameters of pore size in the samples was
measured from ten random fields of SEM micrographs
(300x magnification) using image analyzing program Ima-
geJ (US National Institute of Health, Bethesda, MD).
2.5 In vitro SSCs-scaffold interaction
2.5.1 SSCs isolation and cell culture
Ten 3–6-day-old male mice from the National Medical
Research Institute, initially from the original stocks of Razi
Laboratory (Tehran, Iran), were used in the experiment.
The animals were kept in cages at a temperature of 25 °C,
with a 12-h light and dark cycle. The animals had free
access to drinking water and standard laboratory pellets.
The research was conducted in accordance with the
National Research Council guidelines. Testes were isolated
and randomly assigned to two experimental groups: two
dimensional (control) and three-dimensional (experiment)
for in vitro SSCs cultured for MTT, SEM, and H&E
assessment on scaffold.
The testes were collected and suspended in PBS sup-
plemented with penicillin (100 IU/mL), streptomycin
(100 μg/m). SSCs were isolated based on the method
described previously [26]. Briefly, the testes were placed in
Dulbecco’s Modified Eagle medium (DMEM/F12) includ-
ing 0.5 mg/mL collagenase ІV (Sigma-Aldrich), 0.5 mg/mL
Trypsin (Sigma-Aldrich), and 0.05 mg/mL DNAse (Sigma-
Aldrich, USA), for 30 min with pipetting and stay at 37 °C.
The interstitial cells were removed by washing in DMEM/
F12 medium and it was centrifuged. Plates of cells extracted
and second digestion step was done according to previous
step. Then seminiferous cord fragments removed and cells
extracted by centrifuging.
Primary culture of SSCs was performed in DMEM/
F12 supplemented with 10 ng/mL GDNF (Glial cell line-
derived neurotrophic factor, RP-1107, Royan Institute)
and 2% FBS in (FBS, Gibco), 1 % penicillin-streptomycin
(15140-148, Gibco), and 1% non-essential amino acids
(11140-035, Gibco) for one week. The incubation of the
cells was done at 35 °C, 5% CO2 in a humidified atmo-
sphere, and the medium was replaced three times. After
1 week, the mix of SSCs was used for cells and scaffold
interaction analysis. Prior to culturing on the optimized
scaffold, the cell number was determined by a hematocyt-
ometer. The SSCs viability was also evaluated by the dye
exclusion test (0.04% trypan blue solution).
2.5.2 Identification of SCs by RT-PCR
The isolated SCs was identified by amplification of SSCs
specific genes (Gfrα1 (GDNF family co-receptor α1), Plzf
(promyelocytic leukemia zinc-finger), Id4 (Inhibitor of
DNA Binding 4) and Gapdh genes, as housekeeping gene)
by reverse transcription-polymerase chain reaction (RT-
PCR). Primers were designed using Gene Runner software
(version 3.02; Hastings Software Inc, New York, NY,
USA) and online NCBI primer design software (ncbi.nlm.
nih.gov/tools/primer-blast/). Table 2 shows list of primers
used in this study. Total RNA was extracted using a
standard RNA extraction kit (Qiagen, Hilden, Germany),
according to the manufacturer’s instructions, and con-
firmed by a 260/280 nm optical density absorbance ratio
Table 2 Sequences of primers designed for Identification of SCs by
reverse transcription-polymerase chain reaction (RT-PCR)
Gene name bp Primers sequences Melt
(°C)
Plzf 137 F: CCCGTTGGGGGTCAGCTAGA 61
R: CTGCAAGGTGGGGCGGTGTAG
Gfrα1 130 F: CTGTGGACTAGCTCGCTCTC 60
R: GACCCGCTTTTAGGGGTTCA
Id4 185 F: GGGTGACAGCATTCTCTGC 58.52
R: TTGGAATGACAAGACGAGACG
Gapdh 125 F: CTGCTGGACAAGTGAGTCCC 60
R: CCAAGTACCCTGGCCTCATC
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measurement. 1 μL of PCR products for each amplicon
were run in a 1.2% agarose gel embedded in Tris-Borate-
EDTA (TBE) 1× loading buffer (Sigma-Aldrich) at a vol-
tage of 95 for 45 min. The gels were stained with 0.1 μg/mL
Gel Red™ (Biotium Inc, Hayward, CA, USA) and the
bands were visualized using Gel Logic (Carestream Health
Inc., Rochester, NY, USA) and images were obtained [7].
2.5.3 Cell proliferation and attachment
The scaffolds in the size of 2 × 5 × 5 mm3 were washed with
PBS and were incubated with a culture medium at 35 °C
overnight prior to use. The scaffolds were placed in a
24-well plate, and seeded with 1 × 104 number of SSCs. The
cells-scaffold constructs were incubated in a cell culture
incubator with standard atmosphere at 35 °C for 1, 3, and
7 days. mitochondrial activity for reduction of MTT salt
[27]. The optical density for each sample, representing the
cell viability value, was measured for each sample using a
microplate ELISA reader at a wavelength of 570 nm with a
reference filter of 620 nm. The cell cultured in plastic sur-
face of cell culture plated and medium alone served as
control (100% cell viability).
For assessment of cells-scaffold interaction, the 1 × 106
SSCs were seeded on 1 cm of the scaffold, and then incu-
bated in 5% CO2 for one week at 35 °C. The cell-scaffold
constructs were fixed with 2.5% glutaraldehyde (Merck) for
2 h and dehydrated in a graded concentration (30, 50, 70,
and 100%) of alcohol, and then were lyophilized overnight.
The samples were sputter-coated with gold and observed by
electron microscope (SEM, AIS2100; Seron Technology,
South Korea) at an accelerating voltage of 15 kV.
2.5.4 SSCs colony formation
The optimized decellularized scaffold was investigated
for its potential as a substrate for colony formation of
SSCs. For visualization of colony formation, the re-
cellularized scaffold after 7 days cell culture incubation
time were fixed with 10% formalin, dehydrated through a
graded series of alcohol, embedded in paraffin, and sec-
tioned at 5 µm, as described above. The samples were
stained with H&E and formation of SSCs colony was
observed and investigated under light microscope.
2.6 In vivo biocompatibility assay
In vivo biocompatibility assay was carried out by a pro-
cedure described in our previously published article [28].
For in vivo biocompatibility assay, six NMRI male mice
(6–8 week, 30 g) were obtained from the National Medical
Research Institute, initially from the original stocks of
Razi Laboratory (Tehran, Iran). Anesthesia was done by
intra-peritoneal injection of ketamine (0.1 mg/kg, Anes-
ketin, Heusden–Zolder, Belgium) and xylazine (0.01 mg/
kg, Heusden–Zolder, Belgium). After fixing of mice on a
special table, the operating site was shaved and sterilized
with betadine 10% (Povidone Iodine 10%, Najo, Iran).
The scaffolds in the size of 2 × 5 × 5 mm3 were washed
with PBS and exposed to UV rays for 20 min and
implanted subcutaneously on the back of mice. After
surgical incision and scaffold transplantation, the skin of
the surgical site was sutured with a single absorbable zero
silk thread (Supasil 0.1, Supa, Iran). The animals were
kept in cages at a temperature of 25 °C, with a 12-h light
and dark cycle in pre-implantation and post-implantation
period. The animals had free access to drinking water and
standard laboratory pellets. Short term (7 days) and long
term (30 days) in vivo biocompatibility of the optimized
decellularized scaffold was determined. The mice were
sacrifice by cervical dislocation and implanted tissue was
collected and stained with H&E (n= 6, three samples for day
7 and three samples for day 30). The stained samples were
observed under light microscope. Images were captured on
10 random fields by a light microscope and analyzed by
program ImageJ (US National Institute of Health, Bethesda,
MD). The macrophages, lymphocytes, and fibroblasts cells
infiltrated into the implanted site were investigated.
2.7 Statistical analysis
In the present study, the data analysis was conducted using
Prism 7 and SPSS software for Windows, version 16.0
(SPSS Inc., Chicago, IL, USA). Variables were presented as
the mean ± standard deviation. The analysis of variance
followed by one way ANOVA and Tukey’s post-hoc was
used for multiple group analyses. The p values of < 0.05




The successful removal of the cells and nucleic acids from
the ECM was verified using H&E, DAPI staining, and DNA
quantification. All of the decellularization treatments con-
siderably reduced the DNA content in comparison with the
native placenta samples. The dsDNA in ECM of ST 0.5 for
30min and SDS 0.5 for 30min was also quantified and
compared to the native human placenta, respectively
(28.49 ± 1.78, 33.32 ± 2.2 and 1476 ± 218 ng/mg, mean ±
SD, P ≤ 0.05). The tissue denuded with ST 0.5 for 30min
and SDS 0.5 for 30min detergents observed 1.99 and 2.25%
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of the DNA remained in tissue fragments after the decel-
lularization process, respectively (Supplementary Fig. 1). The
numbers of nuclei/mm2 after H&E staining significantly
decreased after decellularization in all groups compared with
native tissue (P ≤ 0.05) (Fig. 1A, B). The tissue treated with
ST 0.5 for 30min and SDS 0.5 for 30min detergents showed
lowest numbers of nuclei respectively (0.25 ± 0.5, 0.75 ±
0.95 nuclei/mm2, mean ± standard deviation (SD)) compared
with native tissue (2324 ± 133 nuclei/mm2, P ≤ 0.05,
Fig. 1B). Moreover, the number of nuclei/mm2 after DAPI
staining confirmed the H&E results, which significantly
decreased in treated groups compared with control group
(P ≤ 0.05, Fig. 2B). The data obtained from DAPI staining
revealed that the tissue treated with ST 0.5 for 30min and
SDS 0.5 for 30min detergents observed lowest numbers of
nuclei respectively (3.5 ± 7.0, 3.8 ± 7.5 nuclei/mm2, mean ±
SD) compared with control samples (2888 ± 219.6 nuclei/
mm2, P ≤ 0.05, Fig. 2B).
3.1.2 Extracellular matrix components
Placental ECM components such as collagen, elastin, and
GAGs were visualized with Alcian blue, Orcein, and Mas-
son’s trichrome staining, respectively, to determine the
effects of each decellularization protocol on ECM damage.
The results indicated that collagen component decreased in
the tissues after treatment with SDS (P ≤ 0.05). The tissues
decellularized with SDS 0.5% for 30min and ST 0.3% for
30min showed a slight decrease in elastin fibers and GAG
compared with other groups (Figs. 3–5, P ≤ 0.05).
Fig. 1 A Histological analysis of decellularized placenta fragments in
fresh and experimental groups. B The number of nuclei decreased
significantly in all of the decellularization protocols. The cells nuclei
are shown with black arrows. Data are expressed as the mean ± SD,
scale bar in all groups is: 25 µm (****P < 0.0001)
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3.1.3 Mechanical behavior
As shown in Table 3, the SDS groups indicated the lowest
ultimate stress and ultimate strain in comparison with other
samples. Also, the decrease in elastic modulus of the sam-
ples was as follow: control > T samples > ST samples >
SDS samples. The lowest percentages of ultimate strain
observed in SDS samples.
3.1.4 Swelling and degradability behavior assays
The ESR result revealed that the decellularization with
SDS and Triton increased water uptake value compared
with control, although the difference was not significant.
The results also indicated that the swelling ratios increased
with the increase of SDS and Triton concentration and
incubation time (Fig. 6A).
The degradation results during 30 days are shown in
Fig. 6B. Although the tissues denuded with SDS 0.5, 30, and
ST 0.5, for 30min showed the highest degradation rate and
mas loss (%), the difference was not significant when com-
pared with other groups (Fig. 6B).
3.2 Morphology of microstructure of scaffold by
scanning electron microscopy
SEM analysis was done for assessing the microstructure and
pore size of the scaffolds. The means of pore size of the
Fig. 2 A DAPI staining in decellularized placenta fragments in fresh
and experimental groups. B The number of nuclei decreased con-
siderably in all of the decellularization protocols. The cells nuclei are
shown with white arrows. Data are expressed as the mean ± SD, scale
bar in all groups is: 25 µm (****P < 0.0001)
Journal of Materials Science: Materials in Medicine (2021) 32:47 Page 7 of 17 47
scaffolds was 181.5 ± 17, 227.75 ± 49.61, 233.25 ± 63.14 in
control, SDS 0.5%, 30 and ST 0.5% for 30 min groups,
respectively (Fig. 7A, B).
3.3 In vitro SSCs-scaffold interaction
3.3.1 Viability and identification of SSCs
The viability of the SSCs isolated from 3 to 6 days NMRI
mice was 93 ± 2%, determined by trypan blue staining. In
addition, agarose gel electrophoresis confirmed the presence
of mouse spermatogonial genes after two steps of mouse
tastes enzymatic digestion (Fig. 8).
3.3.2 Cell proliferation and attachment
The attachment and proliferation of the SSCs cultured for 1,
3, and 7 days on all the groups of scaffolds were assessed by
MTT assay. Only the placenta treated with SDS 0.5 for
15min and 30min showed a significant decrease in the cell
viability at 3 days of culture, when compared with other
groups (P ≤ 0.05). ST 0.5 for 30min showed no change in
cell viability in all incubation time periods of 1, 3, and 7 days
(P ≥ 0.05, Fig. 8A–C). As only SDS 0.5/30 and ST 0.5/
30 showed full removal of the cells from tissue after decel-
lularization process, and contrary to SDS 0.5/30, ST 0.5/30
had no negative effects on SSCs viability during 7 days
Fig. 3 A Characterization of extracellular matrix components for
recognition of collagen in the native and experimental tissue fragments
by Masson’s trichrome staining. B The quantification of collagen
revealed that SDS reduced collagen. The cell’s nuclei are shown by
white arrows. All data are expressed as the mean/percentage ± SD,
scale bar: 60 µm (*P < 0.05)
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follow up, ST 0.5/30 was considered as optimized decel-
lularized placental sponge, and subjected to colony formation
and in vivo biocompatibility assays.
The morphology of the SSCs colony grown for 7 days on
ST 0.5/30 scaffold under SEM is shown in Fig. 8F. The
SSCs colony formation was also observed in the tissues
stained with H&E (Fig. 8E).
3.4 In vivo biocompatibility
The cells infiltrated into the subcutaneously implanted ST 0.5/
30 scaffold at short-term (7 days) and long-term (30 days)
post-implantation period are shown in Fig. 9c–f. The number
of infiltrated macrophages increased significantly after 1 and
4 weeks, respectively (21.29 ± 4.95 to 431.9 ± 78.54, nuclei/
mm2, mean ± SD, P ≤ 0.05). Also, the number of infiltrated
lymphocytes increased significantly after 1 and 4 weeks (57 ±
13.11 to 247.7 ± 78.49, nuclei/mm2, mean ± SD, P ≤ 0.05)
and the number of infiltrated fibroblasts increased sig-
nificantly after 1 and 4 weeks (48.71 ± 13.39 to 135.4 ±
21.61, nuclei/mm2, mean ± SD, P ≤ 0.05, Fig. 9).
4 Discussion
In the current study, we used different concentrations of SDS
and Triton, alone and in combination, and two incubation
time periods of 15 and 30min to optimize an effective and
Fig. 4 A Characterization of extracellular matrix components for
detection of GAG in the native and experimental tissue fragments by
Alcian blue staining. B There were no differences between groups
compared to native tissue. All data are expressed as the mean/per-
centage ± SD, scale bar: 60 µm (P > 0.05)
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safe method for decellularization of human placenta and
fabrication of 3-D macroporous scaffold for tissue engi-
neering and reproduction applications. As mentioned earlier
in introduction, decellularization and preservation methods
can remarkably affect the biomechanical and biological
properties of tissue [17, 18]. Therefore, it is very important to
use an optimal concentration and incubation time point of
detergents with successful removal of cells and minimal
negative effects on ECM proteins and growth factors
[17, 29]. In our previous study, we optimized a decellular-
ization procedure for decellularization of amniotic membrane
using chemical agents such as EDTA and NaOH [28].
Placental tissue is very cellular compared amniotic/chorion
membrane and need more aggressive method for successful
decellularization. The ability to translocate cells and genetic
material from tissue determines the importance of the widely
used ionic surfactants such as SDS [30]. SDS showed to have
the ability to complete cell and host DNA removal of rat
forearm [31] porcine cornea [32], porcine heart valve [33],
porcine kidney [34], human vein [35], porcine, and human
lungs [36]. However, the reports revealed that the SDS has
dose-dependent cytotoxicity effects on human cells, and is
extremely destructive to tissue ECM [18, 19]. Therefore,
treatment of tissue with an optimal concentration of SDS and
Fig. 5 A Characterization of extracellular matrix components for detection of elastin in the native and experimental tissue fragments by Orcein
staining. B All data are expressed as the mean/percentage ± SD, scale bar: 60 µm (*P > 0.05)
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complete elimination of SDS from tissue after denudation is
extremely important. Triton X-100 is a nonionic surfactant
which is widely used in cell lysis buffer, protein extraction
solutions, and decellularization of tissues. Triton X-100 has
less destructive effects and decellularization capacity, and
also higher biocompatibility for human cells compared with
SDS. Although Triton has been shown to be able to suc-
cessfully remove the cells from some tissues, this nonionic
agent is almost used after treatment of tissue with SDS, to
promote decellularization process and also eliminate SDS
during washing process [30, 37, 38].
During the evaluation period of decellularization, all of
the samples were stored at -80C° until use, maximum for
1 month. It is well documented that the long-term in vitro
preservation of decellularized tissues can negatively affect
their biological properties [39]. Baiguera et al. decellular-
ized Human tracheas and stored samples for one year in
PBS at 4 °C. The mechanical and immunological properties
of pig decellularized tracheal matrices remain unaffected by
a 2-month storage in PBS. However, the scaffolds were
increasingly degraded in particular of collagenous and
elastic fiber structure [39].
All methods examined in our study significantly reduce
DNA content and removed the cells compared with control
groups. Only the tissues treated with SDS 0.5% and ST 0.5%
both for 30min showed full removal of the cells compared
with other groups, confirmed by DNA count, (<50 ng/mg)
H&E and DAPI staining. The optimal concentration of
decellularization detergents for successful removal of the cells
directly depends on tissue type. For example, 1% Triton and
1% SDS for 24 or 48 h, and 0.1% SDS for 24 h was optimal
for decellularization of human testicular tissue [40] and
ovarian tissues [41], respectively. Compared with Triton, SDS
showed to cause extensive damage to ultrastructure and
mechanical properties of tissues [38, 42]. For example, the
human and porcine lungs treated with SDS showed more
fibrotic structure, ECM damages, and growth factor loss
compared with control (the native tissue) [30, 36]. Based on
the data obtained from Alcian blue, Masson’s trichrome and
orcein staining, only SDS 0.5% for 30min and ST 0.3% for
30min slightly decreased the ECM components of GAGs,
collagen and elastin fibers, but the difference was not sig-
nificant when compared with other groups.
In a study conducted by Vermeulen et al., different
concentrations of SDS (0.01, 0.1, and 1%w/v) were used for
decellularization of immature testicular tissue of 15 piglets.
They reported that only SDS 1% caused a significant
reduction in GAGs and collagen content in comparison with
SDS 0.1% and SDS 0.01% groups, confirmed by Alcian
blue and Masson’s trichrome staining [43]. Our results
revealed that the collagen content considerably decreased in
the SDS groups, while no significant reduction in collagen
was observed in the placentas decellularized with all ST
groups, indicating the protective effects of Triton against
SDS during decellularization process. Collagen is an
important component of the ECM, and our findings in
consistent with previous reports indicating the dose-
dependent degradation activity of the SDS for collagen
fibers [44, 45]. Our data is also confirmed by the findings








Control 1 5.44 ± 0.65 0.38 ± 0.04 34.35 ± 5.33
T3–15 6.96 ± 0.23 0.51 ± 0.02 31.32 ± 1.43
T3–30 6.52 ± 0.15 0.48 ± 0.07 30.12 ± 2.54
T5–15 6.13 ± 0.74 0.45 ± 0.06 28.63 ± 4.29
T5–30 5.94 ± 0.52 0.41 ± 0.01 27.43 ± 5.41
S3–15 3.97 ± 0.91 0.25 ± 0.06 18.121 ± 4.32
S3–30 3.51 ± 0.23 0.21 ± 0.01 16.64 ± 7.12
S5–15 2.91 ± 0.12 0.18 ± 0.05 14.23 ± 4.32
S5–30 2.51 ± 0.43 0.16 ± 0.06 13.56 ± 8.32
ST3–15 5.16 ± 0.38 0.38 ± 0.02 25.23 ± 1.39
ST3–30 4.95 ± 0.71 0.35 ±−0.030 22.23 ± 4.82
ST5–15 4.51 ± 0.39 0.31 ± 0.05 21.12 ± 5.43
ST5–30 4.29 ± 0.65 0.29 ± 0.04 19.84 ± 3.54
Mechanical tensile data are expressed as means ± SD, n= 3
Fig. 6 Swelling and degradability behavior assays. A The equilibrated
swelling ratio of each type of decellullarized scaffolds. B The in vitro
degradation assay of decellullarized scaffolds. Data are expressed as
means ± SD, n= 3
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reported by Willemse and colleagues (2020). They used
Triton alone or in combination with SDS to decellularize
porcine livers. According to their report, Triton + SDS had
higher rate of damages to collagen and GAGs compared
with those tissues treated with Triton alone [46].
The effects of detergent concentrations and incubation
time during decellularization process on mechanical prop-
erty, degradation rate, swelling value, and pore size were
also determined in our study.
Our investigations revealed that the mechanical properties
of the decellularized placental scaffold decreased with the
increase of SDS concentration and incubation time. This
might be due to the destructive effects of SDS in higher dose
on tissue ECM structural proteins. The same result was
reported by Gilpin et al. They demonstrated a significant
reduction in elastic and viscous moduli reduction with the
increase of the SDS concentration and incubation time [30].
In our study, the percentage of scaffolds degradation
slowly increased with increasing the incubation time, the
weight of the scaffold remained intact, nearly 80 percent,
following 30 days incubation. SDS 0.5, 30, and ST 0.5 for
30 min showed the maximum degradation rate because of
having the highest hydrophilicity [47]. The swelling beha-
vior of scaffolds facilitates cell migration, proliferation, and
oxygen absorption and waste disposal [48]. We observed
that the percentage of swelling slowly increased with the
increase of the incubation time. Two groups of SDS 0.5, 30
and ST 0.5 for 30 min showed the maximum absorption of
water after 72 h, about 60%, which is consistent with the
similar investigations elsewhere [47]. Pore size is critical
Fig. 7 A The microstructure and pore size of the scaffolds. B Data are expressed as means ± SD, scale bar: 100 µm, n= 5
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features for cell attachment, proliferation, and migration
[49]. By increasing the concentration and time of detergents
for decellularization, we observed an increase in the average
of scaffolds pore size. The groups SDS 0.5, 30 ST 0.5 for
30 min showed the maximum pore size and minimum nuclei
number, although the difference was not significant when
compared with other groups.
The cytobiocompatibility of the scaffolds was determined
by MTT assay. According to cell proliferation assay, a sig-
nificant reduction in mitochondrial activity of SSCs, repre-
senting the cell number present at the time, was observed in
the SDS 0.5/15 and SDS 0.5/30 groups after 3 days of
culture. MTT results at day 7 post-culture showed that the
ST 0.5 for 30 min did not change the proliferation and
attachments of SSCs, confirming that the treatment of the
SDS-treated samples with Triton and washing with PBS can
successfully increase its cytobiocompatibility property. This
finding may be due to reducing the concentration of the
residual SDS to a nontoxic level and increased cells
attachments to the scaffold after washing the SDS-treated
tissue with Triton [30, 50]. Among the twelve decellular-
ization procedures, only ST 0.5 for 30 min showed all the
optimal characteristics together, such as successful cell
removal, cytobiocompatibility for SSCs growth and colony
Fig. 8 In vitro biocompatibility and bioactivity. A–C The scaffolds
were placed in a 24-well plate, and seeded with 1 × 104 number of
SSCs. The cells-scaffold constructs were incubated in a cell culture
incubator. MTT assay after 1 (A), 3 (B) and 7 (C) days of culture
evaluated. D SSCs cultured indirectly in the bottom of the plates, with
the presence of ST 0.5 30 scaffold and colony formation observed after
7 days. E H&E staining confirmed SSCs 3-D colony formation into the
scaffold after 7 days. F SEM results confirmed SSCs 3-D colony
formation onto the scaffold after 7 days. SSCs colonies are shown by
white arrows. **P < 0.05. Data are expressed as means/percentage ±
SD, n= 3
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formation and minimal damages to ECM. The SSCs colony
was clearly observed after 7 days culture on the ST 0.5/
30 scaffold. Both SEM micrographs and H&E stained
samples showed well attachment and growth of the SSCs
colony within scaffold’s pores. The in vivo examination of
the optimized scaffold (ST 0.5/30) showed that the host cells
were penetrated into the scaffolds’ pores with no sign of
graft rejection or acute inflammatory response during short-
term (7 days) and long-term (30 days) post-implantation
follow up. Scaffold implantation caused the vascularization
of connective tissue in the injured place and leads to the
release of inflammatory responses. The number of infiltrated
fibroblasts, macrophages, and lymphocytes increased sig-
nificantly after one and four weeks which is consistent with
the data published previously [28, 51]. The macrophages
play the main role in the degradation of biological scaffolds
Fig. 9 Biocompatibility of the scaffold in vivo. A, B Subcutaneous
implantation of the scaffold in mouse model. After short-term (1 week)
and long-term (4 week), the implanted site were collected and stained
with H&E. The implanted scaffold is shown by white arrow. C A
semi-quantitative scoring of the cells infiltrated into the implanted
scaffold. The infiltrated macrophage, lymphocyte and fibroblast are
shown with white, black and blue arrows, respectively. D H&E stained
slide of normal skin with no implantation as negative control. H&E
stained samples after implantation of the scaffold after short-term
(1 weeks) (E) and long-term (4 weeks) (F) periods
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[52]. All the data obtained from the current study revealed
the successful removal of the cells from tissue after decel-
lularization process and favorable mechanical property and
cytobiocompatibility both in vitro and in vivo.
5 Conclusions
According to our in vitro and in vivo investigations, the
placenta tissue treated with %0.5 ST for 30 min show a
successful removal of the cells with minimal negative
effects on ECM components, uniform porous micro-
structure with interconnected network and cytobiocompat-
ibility. The %0.5/30 ST placenta macroporous scaffold is
suggested as an excellent substrate for proliferation, growth,
and colony formation of spermatogonial cells.
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